AGORA PRS – Scientific Platform Special Seminar
AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
PhD Thesis Defense | September 25th
AGORA PRS – Special seminar | September 26th
Oncology Grand Rounds, Dr. Marcus Vetter | September 29th
AGORA Single-cell omics meetings | October 4th
Symposium Fondation Jeantet | October 10th
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.
Bobisse S, Bianchi V, Tanyi JL, (…), Kandalaft LE, Harari A, Coukos G
Nature Cancer – 2023 Sep 21
Reductive carboxylation epigenetically instructs T cell differentiation.
Jaccard A, Wyss T, Maldonado-Pérez N, (…), Romero P, Ho PC, Wenes M
Nature – 2023 Sep 20
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy of Multiple Myeloma Using [(99m)Tc]Tc-PentixaTec.
Enke JS, Reitsam NG, Grosser B, (…), Schottelius M, Lapa C, Pfob CH
Journal of nuclear medicine – 2023 Sep 14
Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8(+) T cell exhaustion.
Tillé L, Cropp D, Charmoy M, (…), Carmona SJ, Held W, Verdeil G
Nature immunology – 2023 Sep 14
Dendritic cells as shepherds of T cell immunity in cancer.
Pittet MJ, Di Pilato M, Garris C, Mempel TR
Immunity – 2023 Sep 8